GSE171180,GSE171181 0 V 1 E7107 HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE171180,GSE171181 0 V 1 E7107 HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE171180,GSE171181 0 V 1 E7107 HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE171180,GSE171181 0 V 1 E7107 HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE171180,GSE171181 0 V 1 E7107 HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

ATP5MF-PTCD1 readthrough

Gene

Myb/SANT DNA binding domain containing 5

Gene

solute carrier family 25 member 25

Gene

VRK serine/threonine kinase 3

Gene

dynein axonemal light intermediate chain 1

Gene

solute carrier family 25 member 33

Gene

F-box DNA helicase 1

Gene

cell death inducing p53 target 1

Gene

zinc finger protein 808

Gene

lysine methyltransferase 2B

  • Gene

    ATP5MF-PTCD1 readthrough


  • Gene

    Myb/SANT DNA binding domain containing 5


  • Gene

    solute carrier family 25 member 25


  • Gene

    VRK serine/threonine kinase 3


  • Gene

    dynein axonemal light intermediate chain 1


  • Gene

    solute carrier family 25 member 33


  • Gene

    F-box DNA helicase 1


  • Gene

    cell death inducing p53 target 1


  • Gene

    zinc finger protein 808


  • Gene

    lysine methyltransferase 2B

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.